SOME PERSPECTIVE RADIONUCLIDES IN THE NUCLEAR MEDICINE OF KAZAKHSTAN

2018

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.52676/1729-7885-2018-1-31-35
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

It is necessary to replenish the kit of the domestic generator 99mTc with new reagents, which expand the possibilities of radionuclide examination of organs and systems. It should be possible to release an ideal diagnostic pair for therapeutic radiopharmaceuticals, such as 123I for less affordable 131I. Establishing the production and cardiomyotropic and parathyroid tropic radiopharmaceutical 201Tl is important. Scintigraphy is one of the most informative imaging techniques. 68Ge/68Ga generator in accordance with the term of operation for two years, provides cancer specific pharmaceutical to oncological clinics, which is an alternative to expensive cyclotron radionuclides.